Navigation Links
Andrea Drucker Joins Insmed as General Counsel
Date:7/18/2011

ement team."

"I am excited to be joining the Insmed management team, and look forward to working with the Company as ARIKACE® (liposomal amikacin for inhalation) continues to move forward on its development path through to potential commercialization," said Ms. Drucker.

Ms. Drucker received her J.D. from the University of Pennsylvania Law School and a Bachelors of Science with Distinction in Environmental Studies from Cornell University.  

About Insmed

Insmed Incorporated is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases.  Insmed's primary focus is on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to our financial positions, results of operations, the results of clinical trials and clinical data described herein, the development of our products, and the business strategies, plans and objectives of management, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements.  Our results may be affected by such factors as the receipt and timing of FDA and other regulatory approvals, if at all, competitive developments affecting our product development, delays in product development or clinical trials, and patent disputes involving currently developing products.  The risks and uncertainties include
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Coloredge New York - Los Angeles Joins DuPont™ Tyvek® Graphics Authorized Printer Network
2. Jeff Sherman Joins Block Engineering as Vice President of Worldwide Sales
3. Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board
4. Dr. Joel Posener Joins PharmaNet as Executive Medical Director, Neuroscience
5. Eduard Alberts, Ph.D. Joins Sanford Rose Associates - San Francisco
6. Amicus Therapeutics Joins Russell 3000® Index
7. Dr. H. Daniel Perez Joins Celtaxsys Board of Directors
8. Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board
9. Matthias Spaenle, MD, Joins Oppenheimers Investment Banking Group as Managing Director - Healthcare
10. William T. Boehm Joins Neogens Board of Directors
11. Scott Garrett Joins Water Street Healthcare Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 Many of us ... for certain infants with rare, inherited mutations of ... consequences of their impaired immune responses. ... identified an important role for calcium signaling in ... tuberculosis, the bacterium causing tuberculosis (TB). ...
(Date:5/4/2015)...   St. Jude Children,s Research Hospital ... for finding genetic alterations that play an important ... identify with whole-genome sequencing. The findings appear today ... The tool is an algorithm called ... Tree in Next Generation Sequencing. ...
(Date:5/4/2015)... N.Y. , May 4, 2015  Traverse ... $250,000 cooperative research and development agreement (CRADA) with ... advance the development of TRB-N0224 for the treatment ... including dogs and cats.  Traverse Biosciences has also ... for the treatment and control of periodontal disease ...
(Date:5/4/2015)... May 4, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... an independent team of researchers from ... B4 (TB4) plays an important role in accelerating ... in an experimental mouse model, by promoting blood ... damaged dermal tissue.  The research found that the ...
Breaking Biology Technology:Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 3Scientists dramatically improve method for finding common genetic alterations in tumors 2Scientists dramatically improve method for finding common genetic alterations in tumors 3Scientists dramatically improve method for finding common genetic alterations in tumors 4Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 2Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 3Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 4Researchers Report that Thymosin B4 has a Major Role in Dermal Burn Wound Healing 2Researchers Report that Thymosin B4 has a Major Role in Dermal Burn Wound Healing 3
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced ... year 2011 financial results on Wednesday, February 8, 2012, after ... a conference call at 5:00 p.m. ET, which will be ... conference call, the company will review the financial results and ...
... 1, 2012  Generex Biotechnology Corporation (OTCBB: GNBT.OB) announced ... Inc., has been awarded a Japanese Patent centering ... immunotherapeutic vaccines.  A number of products developed with ... patent helps to secure the novel Antigen Express ...
... The report " Biomarkers Market (Discovery ... & Forecasts (2011   -   2020) " , ... drivers, restraints, and opportunities in North America, Europe, Asia, and ... data tables and in-depth TOC on the   ...
Cached Biology Technology:Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast 2Generex Announces Patent Award for its Core Vaccine Technologies in Japan 2Generex Announces Patent Award for its Core Vaccine Technologies in Japan 3Generex Announces Patent Award for its Core Vaccine Technologies in Japan 4MarketsandMarkets: Global Biomarkers Market worth $25.79 Billion by 2016 2MarketsandMarkets: Global Biomarkers Market worth $25.79 Billion by 2016 3
(Date:4/6/2015)... , Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... provisional patent 62/143028 for MINIATURE, MULTI-PURPOSE ... TRANSFER  NXT-ID introduces a new revolutionary ... patent surrounds the use of miniature antenna modules ...
(Date:4/1/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces the second shipment ... underway to early access pre-order customers. ... retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop ... accepted at all outlets and very easy to use. ...
(Date:3/26/2015)... 26, 2015 The Granite Club, ... and athletic club, today announced it has implemented a ... of movement for members and staff, while restricting access ... process, we selected FST,s IMID Access system because it ... our members and staff, in addition to unparalleled security," ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... Hospital have discovered that a certain differentiated cell type ... requires the constant expression of a gene called Prox1 ... Prox1 acts as a two-way switch whose inactivity is ... a lymphatic endothelial cell (LEC). In the absence of ...
... promotes the growth of new nerves and the branching ... more aggressive tumors, said researchers from Baylor College of ... appears today in the journal Clinical Cancer Research ... the growth of nerves, but this is the first ...
... issue of BioScience includes a Special Section consisting ... by Louis J. Guillette, Jr., of the University of Florida. ... is as follows: Meeting the Challenges of Aquatic ... and Matthew L. Rise. , As a model organism for ...
Cached Biology News:Reprogrammable cell type depends on a single gene to keep its identity 2Prostate cancer spurs new nerves 2BioScience tip sheet, December 2008 2
...
...
... SureLINK HRP Conjugation Kits are based ... conjugates that are consistent and reproducible. ... to conjugate your protein or antibody, ... storage buffer. Activated HRP is ...
Convenient 10X buffer concentrate used to maximize binding to the solid phase in microwell ELISA. Formulated to provide optimal pH and ionic strength for binding of antibodies and some antigens. Co...
Biology Products: